FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3192922 · Received June 27, 2013

Report

Report Number
1030489-2013-02578
Event Type
Injury
Date Received
June 27, 2013
Report Date
February 22, 2017
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2012, THE PATIENT UNDERWENT A SURGICAL PROCEDURE WHERE RHBMP-2/ACS WAS MIXED WITH ALLOGRAFT AND AUTOGRAFT AND WAS WRAPPED AROUND 10ML OF MASTERGRAFT MATRIX, AND PLACED OVER THE PATIENT¿S DECORTICATED SPINE FROM L1 TO L2, USING A POSTERIOR APPROACH. IN (B)(6) 2012, THE PATIENT DEVELOPED A VERY LARGE SEROMA IN HER LUMBAR SPINE. REPORTEDLY, THIS WAS AN INFLAMMATORY REACTION THAT NECESSITATED ANOTHER SURGERY. THE PATIENT HAS REQUIRED EXTENSIVE MEDICAL TREATMENT, INCLUDING HAVING TO UNDERGO ADDITIONAL SURGERIES. THE PATIENT HAS NEVER RECOVERED FROM HER SURGERY INVOLVING RHBMP-2/ACS, AND SHE CONTINUES TO HAVE DAILY SEVERE DISABLING PAIN THAT PREVENTS HER FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
293605 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA M111059AAL

Patients

Seq Age Sex Outcome Treatment
1 00057 YR Required Intervention